E-LIB Suche - Ergebnisse für: Samanen, James M.

1

Phenylbutyrates as potent, orally bioavailable vitronectin ..:

Miller, William H ; Manley, Peter J ; Cousins, Russell D...
Bioorganic & Medicinal Chemistry Letters. 13 (2003) 8 - p. 1483-1486 , 2003

Link: https://doi.org/10.1016/..

2

Discovery of Orally Active Nonpeptide Vitronectin Receptor ..:

Miller, William H. ; Alberts, Doreen P. ; Bhatnagar, Pradip K....
Journal of Medicinal Chemistry. 43 (1999) 1 - p. 22-26 , 1999

Link: https://doi.org/10.1021/..

3

Conformational Preferences in a Benzodiazepine Series of Po..:

Keenan, Richard M. ; Callahan, James F. ; Samanen, James M....
Journal of Medicinal Chemistry. 42 (1999) 4 - p. 545-559 , 1999

Link: https://doi.org/10.1021/..

4

Discovery of an imidazopyridine-containing 1,4-benzodiazepi..:

Keenan, Richard M. ; Lago, M.Amparo ; Miller, William H....
Bioorganic & Medicinal Chemistry Letters. 8 (1998) 22 - p. 3171-3176 , 1998

Link: https://doi.org/10.1016/..

5

The use of rabbit intestinal permeability as an in vitro as..:

Samanen, James M. ; Lee, Chao-Pin ; Smith, Philip L....
Advanced Drug Delivery Reviews. 23 (1997) 1-3 - p. 133-142 , 1997

Link: https://doi.org/10.1016/..

6

Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) ..:

Keenan, Richard M. ; Miller, William H. ; Kwon, Chet...
Journal of Medicinal Chemistry. 40 (1997) 15 - p. 2289-2292 , 1997

Link: https://doi.org/10.1021/..

7

Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine G..:

Samanen, James M. ; Ali, Fadia E. ; Barton, Linda S....
Journal of Medicinal Chemistry. 39 (1996) 25 - p. 4867-4870 , 1996

Link: https://doi.org/10.1021/..

8

Structure-activity relationships in 3-oxo-1,4-benzodiazepin..:

Miller, William H. ; Ali, Fadia E. ; Bondinell, William E....
Bioorganic & Medicinal Chemistry Letters. 6 (1996) 21 - p. 2481-2486 , 1996

Link: https://doi.org/10.1016/..

9

Enantiospecific synthesis of SB 214857, a potent, orally ac..:

Miller, William H. ; Ku, Thomas W. ; Ali, Fadia E....
Tetrahedron Letters. 36 (1995) 52 - p. 9433-9436 , 1995

Link: https://doi.org/10.1016/..

10

The in vitro pharmacological profile of SK&F 106760, a nove..:

Nichols, Andrew J. ; Vasko, Janice A. ; Valocik, Richard E....
Thrombosis Research. 75 (1994) 2 - p. 143-156 , 1994

Link: https://doi.org/10.1016/..

11

Design of a potent and orally active nonpeptide platelet fi..:

Bondinell, William E. ; Keenan, Richard M. ; Miller, William H....
Bioorganic & Medicinal Chemistry. 2 (1994) 9 - p. 897-908 , 1994

Link: https://doi.org/10.1016/..

12

Refinement of a molecular model of angiotensin II (AII) emp..:

Samanen, James M. ; Peishoff, Catherine E. ; Keenan, Richard M..
Bioorganic & Medicinal Chemistry Letters. 3 (1993) 5 - p. 909-914 , 1993

Link: https://doi.org/10.1016/..

13

The chemistry of prohomoerythrinadienone I:

Marino, J.P. ; Samanen, James M.
Tetrahedron Letters. 14 (1973) 46 - p. 4553-4556 , 1973

Link: https://doi.org/10.1016/..

14

Mode of Action for Linear Peptide Inhibitors of HIV-1 gp120..:

Biorn, Alyssa C. ; Cocklin, Simon ; Madani, Navid...
Biochemistry. 43 (2004) 7 - p. 1928-1938 , 2004

Link: https://doi.org/10.1021/..

15

The structure and business of biopharmaceutical companies i..:

, In: Introduction to Biological and Small Molecule Drug Research and Development,

Samanen, James - p. 225-253 , 2013

Link: https://doi.org/10.1016/..